Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Valtoco as acute treatment for seizures

Jan. 14, 2020

FDA clears IND for phase Ib/II study of AVB-500 in clear cell renal cell carcinoma

Jan. 14, 2020

Zhejiang Vimgreen Pharma discloses adenosine A2A receptor antagonists

Jan. 14, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

MSD KK receives approval for Pifeltro for treating HIV-1 infection

Jan. 14, 2020

Methylphenidate improves executive functioning in patients with VCI

Jan. 14, 2020

Remdesivir as a potential new therapeutic option for MERS-CoV

Jan. 14, 2020

Jacobio-Beta Pharmaceuticals, Beijing Jacobio Pharmaceuticals patent BET inhibitors

Jan. 14, 2020

PTC Therapeutics describes new compounds for treating Huntington's disease

Jan. 14, 2020

RNF208 as a prognostic biomarker in TNBC

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...